Literature DB >> 9325320

Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells.

M Koshiba1, H Kojima, S Huang, S Apasov, M V Sitkovsky.   

Abstract

Accumulation of extracellular and intracellular adenosine (Ado) under hypoxic conditions or in the absence of adenosine deaminase results in lymphocyte depletion and in severe combined immunodeficiency, which are currently explained by direct intracellular lymphotoxicity of Ado metabolites. In support of the alternative, "signaling" mechanism, we show that extracellular Ado (extAdo) suppresses all tested T cell receptor (TCR)-triggered effector functions of T lymphocytes including the TCR-triggered FasL mRNA up-regulation in cytotoxic T lymphocytes. Strong evidence against the intracellular lymphotoxicity of Ado (and in support of the signaling model) is provided by abrogation of TCR-triggered growth inhibition in Ado-exposed T cells. The brief exposure to Ado was sufficient to observe inhibition of TCR-triggered effector functions. The "memory" of T cells to exposure to extAdo is best explained by sustained increases in cAMP. Selective agonist (CGS21680) and antagonist (ZM241385) of A2A adenosine receptor were used in functional assays and cDNA probes for different sybtypes of adenosine receptors were used in Northern blot studies. A2A receptors are identified as the predominantly expressed subtype of Gs-coupled Ado receptors in T cells. The demonstration of cross-talk between the A2A receptors and TCR in both directions support the possible role of A2A receptors in mechanisms of extAdo-mediated immunosuppression in vivo under adenosine deaminase deficiency and hypoxic conditions in, e.g., solid tumors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9325320     DOI: 10.1074/jbc.272.41.25881

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

Review 1.  A(2A) adenosine receptors in human peripheral blood cells.

Authors:  S Gessi; K Varani; S Merighi; E Ongini; P A Borea
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

Review 2.  Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis.

Authors:  M Cutolo; A Sulli; C Pizzorni; B Seriolo; R H Straub
Journal:  Ann Rheum Dis       Date:  2001-08       Impact factor: 19.103

3.  Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling.

Authors:  S G Apasov; M R Blackburn; R E Kellems; P T Smith; M V Sitkovsky
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 4.  Possible targeting of G protein coupled receptors to manipulate inflammation in vivo using synthetic and natural ligands.

Authors:  J F Kinsel; M V Sitkovsky
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

5.  Adenosine receptor activation ameliorates type 1 diabetes.

Authors:  Zoltán H Németh; David Bleich; Balázs Csóka; Pál Pacher; Jon G Mabley; Leonóra Himer; E Sylvester Vizi; Edwin A Deitch; Csaba Szabó; Bruce N Cronstein; György Haskó
Journal:  FASEB J       Date:  2007-04-03       Impact factor: 5.191

6.  Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers.

Authors:  Lisa Seitz; Lixia Jin; Manmohan Leleti; Devika Ashok; Jenna Jeffrey; Aimee Rieger; Renger G Tiessen; Gerhard Arold; Joanne B L Tan; Jay P Powers; Matthew J Walters; Joyson Karakunnel
Journal:  Invest New Drugs       Date:  2018-12-19       Impact factor: 3.850

7.  In vitro induction of T cells that are resistant to A2 adenosine receptor-mediated immunosuppression.

Authors:  Akio Ohta; J Kjaergaard; S Sharma; M Mohsin; N Goel; M Madasu; E Fradkov; Akiko Ohta; M Sitkovsky
Journal:  Br J Pharmacol       Date:  2008-12-09       Impact factor: 8.739

8.  Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo.

Authors:  Andreas A Erdmann; Zhan-Guo Gao; Unsu Jung; Jason Foley; Todd Borenstein; Kenneth A Jacobson; Daniel H Fowler
Journal:  Blood       Date:  2005-03-03       Impact factor: 22.113

9.  Dendritic cells tolerized with adenosine A₂AR agonist attenuate acute kidney injury.

Authors:  Li Li; Liping Huang; Hong Ye; Steven P Song; Amandeep Bajwa; Sang Ju Lee; Emily K Moser; Katarzyna Jaworska; Gilbert R Kinsey; Yuan J Day; Joel Linden; Peter I Lobo; Diane L Rosin; Mark D Okusa
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

10.  Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury.

Authors:  Ashish K Sharma; Victor E Laubach; Susan I Ramos; Yunge Zhao; George Stukenborg; Joel Linden; Irving L Kron; Zequan Yang
Journal:  J Thorac Cardiovasc Surg       Date:  2009-11-11       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.